A child with lupus is protected by a vaccine-generated shield against Hepatitis A.

Hepatitis A Vaccination for Children with Lupus: What Parents Need to Know

Lena Voss monogram
Lena Voss in Health & Wellness November 2026 • 4 min read.

"A comprehensive guide to understanding the safety and effectiveness of hepatitis A vaccines for children with systemic lupus erythematosus (SLE)."


Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect various parts of the body. In SLE, the immune system mistakenly attacks healthy tissues, leading to inflammation and potential organ damage. Managing SLE involves a multifaceted approach, including medications and preventive measures to reduce the risk of infections.

One such preventive measure is vaccination. Children with SLE are more vulnerable to infections due to their compromised immune systems and the medications they often take to manage their condition. Hepatitis A, a viral liver infection, is particularly concerning in regions with poor sanitation and hygiene. Vaccination against hepatitis A is a safe and effective way to protect children from this potentially serious illness.

This article explores the key aspects of hepatitis A vaccination in children with SLE, drawing on the findings of a recent study that investigated the safety and immunogenicity (ability to produce an immune response) of the hepatitis A vaccine in this specific population. We aim to provide parents and caregivers with the information they need to make informed decisions about their child's health.

AI Search Multiple angles on this topic

From Ancient Outbreaks to Hepatitis A Vaccination

Disease outbreaks resembling hepatitis A have been known since antiquity. Human hepatitis was recognized throughout recorded history, but infectious etiology and the distinction between hepatitis A, or infectious hepatitis, and hepatitis B, or serum hepatitis, were not established until the first half of the 20th century. The two forms of viral hepatitis were clearly differentiated during World War II. Development of the present killed hepatitis A vaccine depended on breakthrough discoveries made during the preceding 25 years.

Why is Hepatitis A Vaccination Important for Children with Lupus?

A child with lupus is protected by a vaccine-generated shield against Hepatitis A.

Children with SLE face a higher risk of infections for several reasons:

Due to the complex interplay between immunosuppressive drugs and the disease itself in SLE patients, the implementation of vaccinations to protect against diseases has been impacted. Systemic Lupus Erythematosus can cause vulnerability to virus such as Hepatitis A (HAV).

  • Weakened Immune System: SLE itself and the medications used to treat it, such as corticosteroids and immunosuppressants, can weaken the immune system, making it harder to fight off infections.
  • Increased Exposure: Children, especially those in daycare or school, are more likely to be exposed to infectious agents.
  • Potential Complications: Infections can trigger flares in SLE symptoms, leading to increased disease activity and potential organ damage.
AI Search Multiple angles on this topic

Immune Response in Immunocompromised Patients

The CDC's 2020 Advisory Committee on Immunization Practices recommendations report that the humoral response to hepatitis A vaccine might be reduced in immunocompromised children and adults. The examples listed include hematopoietic cell transplant recipients, people undergoing chemotherapy, and people with HIV infection. A separate report provides seroprotection rates and mean IgG titers at diagnosis, one year, and three years, with values differing across the groups presented. These findings support attention to immune status when interpreting vaccine responses.

Limits of the Available Evidence

A systematic literature review of vaccination in pediatric autoimmune inflammatory rheumatic diseases reported that efficacy was not evaluated and that all included studies assessed immunogenicity. The review also noted a good correlation between antibody concentration and protection against infection. Separately, a 2026 analysis of Vaccine Adverse Event Reporting System data from 1990 through 2025 examined vaccine-associated systemic lupus erythematosus, while stating that relationships between vaccines and SLE remain unclear. These sources therefore point to evidence limitations and unresolved questions rather than establishing a vaccine-related cause of lupus.

Two-Dose Vaccination and Immune Response

The CDC Hepatitis A Vaccine Information Statement says that children need two doses of hepatitis A vaccine. In a prospective observational controlled study of children and young adults with autoinflammatory diseases receiving canakinumab or tocilizumab, 24 of 24 patients had positive anti-HAV IgG after two doses, compared with 33 of 39 healthy controls, or 84.6%, with a reported p value of 0.04. A study of childhood-onset systemic lupus erythematosus was designed to compare the immunogenicity and safety of inactivated hepatitis A vaccination in patients with lupus and healthy subjects. Inactivated, or killed, vaccines are generally described as safe for people with lupus in the cited vaccination materials.

Hepatitis A, while often mild in young children, can cause more severe symptoms in older children and adults, including fever, fatigue, jaundice (yellowing of the skin and eyes), abdominal pain, and liver damage. In rare cases, it can lead to acute liver failure, requiring hospitalization and even liver transplantation. Vaccination offers a safe and effective way to prevent this infection and its potential complications.

The Bottom Line: Safe and Effective Protection

The study's findings offer reassurance to parents of children with SLE. The inactivated hepatitis A vaccine is safe, well-tolerated, and effective in this population. While antibody levels may be slightly lower compared to healthy children, the seropositivity rate is still adequate, providing protection against hepatitis A infection. By consulting with their child's doctor and staying informed, parents can make the best decisions to protect their child's health and well-being.

AI Search Multiple angles on this topic

What the Evidence Says About Lupus Risk

A 2024 meta-analysis examined the potential link between vaccination and systemic lupus erythematosus. The researchers systematically searched PubMed, the Cochrane Library, and Embase for observational studies published through September 3, 2023. They assessed study quality with the Newcastle-Ottawa Scale and conducted statistical analyses. The source describes an investigation of the potential association rather than a settled causal conclusion.

Continuing Research and Vaccine Innovation

A recent article focused on hepatitis A vaccination in children with childhood-onset systemic lupus erythematosus and discussed safety and effectiveness for families. A 2025 Hepatitis A Pipeline Insight report described an evolving landscape of vaccine innovation, clinical activity, and market dynamics aimed at reducing the disease's impact, especially in high-risk groups. The Lupus Foundation of America states that staying up to date on vaccines is especially important for people with lupus. Together, these sources point to continued attention to pediatric lupus vaccination and broader hepatitis A vaccine development.

Comparing Pediatric Lupus Patients With Healthy Subjects

A study of hepatitis A virus vaccination in childhood-onset systemic lupus erythematosus examined the immunogenicity and safety of inactivated hepatitis A vaccination in patients with lupus and healthy subjects. Its stated rationale was that vaccination with non-live vaccines may decrease vaccine-preventable infections and mortalities in people with systemic lupus erythematosus. The study therefore addresses a practical concern for families: whether an inactivated hepatitis A vaccine can produce an immune response while maintaining safety in children with childhood-onset lupus.

How hepatitis A findings fit the wider lupus vaccination evidence

Evidence from other vaccines shows that immune response can vary with lupus disease activity, immunosuppressive treatment, prednisone exposure, and renal failure. This provides clinical context for interpreting antibody results, but it is not a hepatitis A finding.[1]

The broader lupus vaccination literature describes a tension between preventing infection and concern about live-vaccine infection or vaccine-associated lupus flares. That context explains why vaccine type and immune status matter when results are interpreted.[1]

Guidance on immunocompromised populations states that the humoral response to hepatitis A vaccine might be reduced in some children and adults, including people receiving chemotherapy, people with HIV infection, and hematopoietic cell transplant recipients. This is a general immunocompromised-population context, not a direct estimate for children with lupus.[2]

What antibody studies leave unresolved in childhood lupus

  • The available pediatric autoimmune vaccination literature evaluated immunogenicity rather than clinical efficacy. Antibody concentration correlates with protection, but the evidence does not directly establish how often vaccination prevents infection in these populations.[3]
  • A reported study limitation was insufficient power to distinguish treatment groups or relate disease activity to antibody loss. Its baseline immunology testing also did not include further B-cell function studies.[4]

Questions about vaccine context

Can hepatitis A spread before symptoms appear?

Yes. A person infected with hepatitis A can transmit the virus even without symptoms.[5]

Sources

  1. Recommendations and Barriers to Vaccination in Systemic Lupus Erythematosus - PMC (pmc.ncbi.nlm.nih.gov)
  2. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020 | MMWR (www.cdc.gov, 2021)
  3. Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRE (exa.ai, 2022)
  4. TITLE PAGE (discovery.ucl.ac.uk)
  5. Hepatitis A Vaccine VIS (cdc.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

Why is it so important for kids with lupus to get the Hepatitis A vaccine?

Hepatitis A vaccination is crucial for children with Systemic Lupus Erythematosus (SLE) because their weakened immune systems, due to both the disease and its treatments like corticosteroids and immunosuppressants, make them more susceptible to infections. Children are also generally exposed to more infectious agents. Hepatitis A can cause severe symptoms, including liver damage and potential complications. Vaccination provides a safe and effective way to prevent the infection and its associated risks, offering vital protection for vulnerable children.

2

What exactly is Systemic Lupus Erythematosus (SLE), and how does it affect kids?

Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the immune system mistakenly attacks healthy tissues, leading to inflammation and potential organ damage. This condition, along with the medications used to manage it, can weaken the immune system, making children with SLE more vulnerable to infections. Effective management of SLE involves a multifaceted approach, including preventive measures like vaccination to mitigate the risk of infections.

3

How does the Hepatitis A vaccine actually work, especially in children who have lupus?

The Hepatitis A vaccine works by stimulating the body's immune system to produce antibodies against the Hepatitis A virus. This process is known as immunogenicity. In children with Systemic Lupus Erythematosus (SLE), the vaccine's safety and ability to generate a sufficient immune response are crucial. Studies show that the inactivated Hepatitis A vaccine is safe, well-tolerated, and effective in children with SLE. While antibody levels may be slightly lower compared to healthy children, the rate at which the body generates these antibodies, known as the seropositivity rate, remains adequate to provide protection against Hepatitis A infection.

4

Why do medications like corticosteroids and immunosuppressants matter when considering the Hepatitis A vaccine for my child?

Corticosteroids and immunosuppressants, commonly prescribed medications for managing Systemic Lupus Erythematosus (SLE) in children, can weaken the immune system. These medications suppress the immune response to prevent the body from attacking its own tissues. However, this also makes children more vulnerable to infections, including Hepatitis A. This is why preventive measures like vaccination are especially important for children with SLE to protect them from potentially serious illnesses.

5

Is the Hepatitis A vaccine really safe for my child who has lupus?

The inactivated Hepatitis A vaccine is generally considered safe for children with Systemic Lupus Erythematosus (SLE). Studies have shown that it is well-tolerated in this population. While the antibody levels produced may be slightly lower compared to healthy children, the seropositivity rate is still adequate, meaning that it provides effective protection against Hepatitis A infection. Parents should consult with their child's doctor to address any specific concerns and make informed decisions about vaccination.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.